CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for INverso Corp. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

INverso Corp.
155 Revere Dr Ste 10
Phone: (847) 291-7711p:847 291-7711 NORTHBROOK, IL  60062-1558  United States
On 12/10/2015, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of INverso Corp. for failure to make required periodic filings with the Commission.
Business Summary
INverso Corp., is a research-based company. The Company is engaged in the discovery and development of medical treatments for humans. During the fiscal year ended June 30, 2009 (fiscal 2009), the Company’s medical treatments in development included central nervous system disorders, infectious diseases and oncology. As of June 30, 2009, it had not generated any revenues.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20096/30/2009YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer, President William A.Hartman 68 9/9/2009 9/9/2009
Treasurer, Director Bonnie L.Hartman 65 9/9/2009 9/9/2009
Secretary Randall S.Goulding 59 9/9/2009 10/6/2006
Director - Marketing and Planning, Director Heidi H.Carl 39 9/9/2009 9/9/2009

Business Names
Business Name
INVERSO CORP
INverso Corp.

General Information
Outstanding Shares: 49,232,890 (As of 11/20/2009)
Shareholders: 15
Federal Tax Id: 341996527


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023